Dublin, July 24, 2017 -- The "Global Nerve Repair Biomaterials Market - Trends and Forecast to 2024" report has been added to Research and Markets' offering.
Global Nerve Repair Biomaterials Market is Expected to Reach USD 775.6 Million by 2024, at a CAGR of 11.3% During the Forecast Period of 2017 to 2024
The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
The global nerve repair biomaterials market is witnessing a rapid growth due to increasing geriatric population, increasing incidence of nerve injuries and neurological disorders, favourable reimbursement policies, and increased government funding. The demand for nerve repair biomaterials is increasing in the hospitals followed by ambulatory trauma centres due to increasing aging population and rising number of nerve injuries and nerve surgeries.
Key Topics Covered:
1 Introduction
1.1. Overview of the Nerve Repair Biomaterials Market
1.2. Market Segmentation & Coverage
1.2.1. Currency and Pricing
1.2.2. Limitation
1.2.3. Stakeholders
2 Research Methodology
2.1. Key Takeaways
2.2. Arriving at the Global Nerve Repair Biomaterials Market Size
2.2.1. Market Crackdown Approach
2.2.2. Company Revenue and Market Share Analysis
2.2.3. Data Triangulation
2.2.4. Key Data Points from Primary Sources
2.2.5. Key Data Points from Secondary Sources
2.2.6. Porter's Five Forces Matrix
2.4. Global Nerve Repair Biomaterials Market: Research Snapshot
2.5. Assumptions
3 Market Landscape Summary
4 Premium Insights
4.1. Overview
4.2. Global Nerve Repair Biomaterials Market: Key Primary Insights
4.3. Market Overview
4.3.1. Drivers
4.3.1.1. Increasing Incidences of Peripheral Nerve Injuries
4.3.1.2. Technological Development in Nerve Repair
4.3.1.3. Favorable Reimbursement Policies
4.3.1.4. Expanded Target Applications
4.3.2. Restraints
4.3.2.1. Lack of Patient Awareness
4.3.2.2. Lack of Professionals, Including Trained Surgeons
4.3.3. Opportunities
4.3.3.1. Novel Therapies Such as Stem Cell Therapy
4.3.3.2. Rising Acceptance of Emerging Markets
4.3.4. Threats
4.3.4.1. Donor Site Morbidity
4.3.4.2. Inadequate Nerve Regeneration by Conduits
4.4. Key Market Trends and Upcoming Technologies
5 Executive Summary
6 Nerve Repair Biomaterials Market, by Product Type
6.1. Overview
6.2. Nerve Repair
6.2.1. Nerve Conduits
6.2.2. Nerve Grafts
6.2.2.1. Allografts
6.2.2.2. Acellularized Allografts
6.3. Nerve Protection
6.3.1. Nerve Protector
6.3.2. Nerve Wrap
7 Nerve Repair Biomaterials Market, by Injury Type
7.1. Overview
7.2. Epineural Nerve Repair
7.3. Perineural Nerve Repair
7.4. Group Fascicular Nerve Repair
8 Nerve Repair Biomaterials Market, by End User
8.1. Overview
8.2. Hospitals
8.3. Ambulatory Trauma Centers
8.4. Clinics
9 Nerve Repair Biomaterials Market, by Geography
10 Nerve Repair Biomaterials Market: Competitive Landscape
11 Nerve Repair Biomaterials Market, Company Profiles
- Axogen, Inc.
- Checkpoint Surgical, Inc.
- Collagen Matrix, Inc.
- Integra Lifesciences Corporation
- Polyganics B.V.
- Stryker Corporation
- Synovis Micro Companies Alliance, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/hzf5jb/global_nerve
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Genomics, Biomaterials


Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Washington Post Publisher Will Lewis Steps Down After Layoffs
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 



